Jasper Therapeutics, Inc.
JSPR
$0.72
$0.022.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.76M | -1.17M | -9.10M | -18.74M | -26.72M |
| Total Depreciation and Amortization | 21.00K | 21.00K | 290.00K | 229.00K | 258.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.37M | -9.03M | -3.33M | 1.70M | 2.13M |
| Change in Net Operating Assets | 1.19M | -4.36M | -9.73M | -187.00K | 8.88M |
| Cash from Operations | -6.92M | -14.55M | -21.87M | -17.00M | -15.45M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -7.00K |
| Sale of Property, Plant, and Equipment | 80.00K | -- | 0.00 | 0.00 | 8.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.00K | -- | 0.00 | 0.00 | 1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.00K | -- | -- | 28.39M | 6.16M |
| Repurchase of Common Stock | -- | -- | -340.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.00K | -- | -340.00K | 28.39M | 6.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.83M | -14.55M | -22.21M | 11.39M | -9.29M |